pegcetacoplan 15 MG in 0.1 ML Injection

RxCUI
2630847
RxNorm name
pegcetacoplan 15 MG in 0.1 ML Injection
Display name
pegcetacoplan 15 MG in 0.1 ML Injection
Full name
pegcetacoplan 15 MG in 0.1 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:17

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SyfovrePEGCETACOPLANApellis Pharmaceuticals, Inc.b4434e61-9ec9-4e0e-bd60-45aaa0a87e642025-09-16Warnings, Adverse reactionsExact identifier
rxcui: 2630847

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b4434e61-9ec9-4e0e-bd60-45aaa0a87e64pegcetacoplan 15 MG in 0.1 ML Injection [PSN] · 0.1 ML pegcetacoplan 150 MG/ML Injection [SCD] · pegcetacoplan 15 MG per 0.1 ML Injection [SY]312These highlights do not include all the information needed to use SYFOVRE safely and effectively. See full prescribing information for SYFOVRE. SYFOVRE ® (pegcetacoplan injection), for intravitreal use Initial U.S. Approval: 202120250916